Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Completed 4

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 113Neoplasm Metastasis 5Carcinoma, Intraductal, Noninfiltrating 5Polycystic Ovary Syndrome 4Ovarian Neoplasms 4Osteoporosis 4Neoplasms 4Infertility 4Breast Neoplasms, Male 4Arthralgia 4Fallopian Tube Neoplasms 3Triple Negative Breast Neoplasms 2Pain 2Leiomyosarcoma 2Leiomyoma 2Endometrial Neoplasms 2Cystadenocarcinoma, Serous 2Breast Carcinoma In Situ 2Bone Diseases, Metabolic 2Advanced Breast Cancer 2Uterine Neoplasms 1Recurrence 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Cysts 1Osteitis Deformans 1Obesity 1Multiple Endocrine Neoplasia Type 1 1Medullary cystic kidney disease 1 1Lymphoma, Non-Hodgkin 1

Interventions

Zoledronic Acid 8Letrozole 4Vitamin D 3Calcium 3Risedronic Acid 2Nutrition Assessment 2Denosumab 2Cholecalciferol 2Calcium Gluconate 2Calcium Carbonate 2Aromatase Inhibitors 2parathyroid hormone-related peptide (1-36) 1Technetium 1Resistance Training 1Radiotherapy 1Observation 1Kyphoplasty 1Ibandronic Acid 1Gonadotropin-Releasing Hormone 1Geritol 1Calcium Citrate 1Anastrozole 1Alendronate 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × Osteoporosis × Letrozole × Clear all
NCT00436917 2019-09-11

Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer

Mayo Clinic

Phase NA Completed
60 enrolled 23 charts
Breast

Breast Neoplasms, Osteoporosis

NCT00111241 2018-12-14

Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors

Monash University

Completed
115 enrolled 6 charts
Breast

Breast Neoplasms, Osteoporosis, Arthralgia, Fractures, Bone

NCT00050011 2014-03-21

Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy

Novartis

Phase 3 Completed
602 enrolled 13 charts
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT00332709 2011-11-16

Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer

Novartis

Phase 3 Completed
83 enrolled 14 charts
Breast

Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡